Allergan has received the product however the device has not been identified nor has the analysis been completed at this time.Based upon the catalog number and implanted date provided by the reporter the connector type is assumed to be a taper ii.Pain and visibility are surgical/physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Device labeling addresses the possible outcome of leakage as follows: "deflation of the band may occur due to leakage from the band, the port or the connector tubing." device labeling addresses the reported event of pain as follows: "there were additional occurrences of these events that were considered to be non-serious.Other adverse events considered related to the lap-band system that occurred in fewer than 1% of subjects included: abdominal pain, chest pain, incision pain and port site pain." device labeling addresses the possible outcome of visibility/palpability as follows: precautions: 6.Care must be taken to place the access port in a stable position away from areas that may be affected by significant weight loss, physical activity, or subsequent surgery.Failure to do so may result in the inability to perform percutaneous band adjustments.
|